BiotechTube
Home/Bsense Bio Therapeutics/Shmuel Tuvia, PhD
ST

Shmuel Tuvia, PhD

Chief Development Officer

Bsense Bio Therapeutics

Therapeutic Areas

PainTinnitusPruritus

Bsense Bio Therapeutics Pipeline

DrugIndicationPhase
BSEN760Chronic PainPhase 1
BSEN761TinnitusPreclinical
BSEN762PruritusPreclinical

Leadership Team at Bsense Bio Therapeutics

DP
Dori Pelled, PhD
Chief Executive Officer
View full Bsense Bio Therapeutics profile